What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
Internal medicine, Endocrinology, Diabetes mellitus, Metabolic syndrome and Type 2 diabetes are his primary areas of study.
Leo Niskanen works mostly in the field of Internal medicine, limiting it down to topics relating to Surgery and, in certain cases, Incidence, as a part of the same area of interest.
His Endocrinology research is multidisciplinary, incorporating elements of Prospective cohort study, Antibody, Cause of death and Confidence interval.
His research in Diabetes mellitus intersects with topics in Physical fitness, Physical exercise and Vascular disease.
The concepts of his Metabolic syndrome study are interwoven with issues in Body mass index, Sex hormone-binding globulin, Cohort study and Testosterone.
His study explores the link between Type 2 diabetes and topics such as Weight loss that cross with problems in Tolerability, Liraglutide and Impaired fasting glucose.
His most cited work include:
- THE METABOLIC SYNDROME AND TOTAL AND CARDIOVASCULAR DISEASE MORTALITY IN MIDDLE-AGED MEN (4401 citations)
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial (1813 citations)
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). (880 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin.
His study connects Surgery and Internal medicine.
His research in Insulin resistance, Cholesterol, Obesity, Glucose tolerance test and Weight loss are components of Endocrinology.
The study incorporates disciplines such as Cohort study, Cohort and Population study in addition to Diabetes mellitus.
His Population study research incorporates themes from Statin and Medical prescription.
Specifically, his work in Metabolic syndrome is concerned with the study of National Cholesterol Education Program.
He most often published in these fields:
- Internal medicine (69.00%)
- Endocrinology (44.74%)
- Diabetes mellitus (33.15%)
What were the highlights of his more recent work (between 2010-2020)?
- Internal medicine (69.00%)
- Diabetes mellitus (33.15%)
- Type 2 diabetes (16.17%)
In recent papers he was focusing on the following fields of study:
Leo Niskanen focuses on Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Population study.
In general Internal medicine, his work in Body mass index, Insulin and Metabolic syndrome is often linked to Intima-media thickness linking many areas of study.
The various areas that he examines in his Metabolic syndrome study include Calcium and Insulin resistance.
His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Blood pressure, Cohort study, Cohort and Intensive care medicine.
His Type 2 diabetes study integrates concerns from other disciplines, such as Metformin, Obesity, Gerontology, Lifestyle intervention and Family medicine.
His biological study deals with issues like Hormone replacement therapy, which deal with fields such as Testosterone.
Between 2010 and 2020, his most popular works were:
- Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial (508 citations)
- Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. (420 citations)
- Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey (113 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Disease
His scientific interests lie mostly in Type 2 diabetes, Internal medicine, Diabetes mellitus, Insulin and Endocrinology.
His Type 2 diabetes research is multidisciplinary, incorporating perspectives in Metformin, Gerontology, Public health and Confidence interval.
His studies in Internal medicine integrate themes in fields like Diabetic nephropathy, Nephropathy and Population study.
His studies deal with areas such as Secondary care, Primary care, Physical health and MEDLINE as well as Diabetes mellitus.
In his work, Cholecystokinin, Appetite, Polyunsaturated fat and Finnish population is strongly intertwined with Food science, which is a subfield of Insulin.
Leo Niskanen studies Endocrinology, namely Metabolic syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
